RCTB-401 ( DrugBank: - )


1 disease
告示番号疾患名(ページ内リンク)臨床試験数
96クローン病1

96. クローン病


臨床試験数 : 2,442 薬物数 : 1,278 - (DrugBank : 248) / 標的遺伝子数 : 142 - 標的パスウェイ数 : 209
No.TrialIDDate_
enrollment
Date_
registration
Public_titleScientific_titleConditionInterventionPrimary_
sponsor
Secondary_
sponsor
Recruitment_
Status
Inclusion_
agemin
Inclusion_
agemax
Inclusion_
gender
Target_
size
PhaseCountries
1EUCTR2005-002048-25-SE
(EUCTR)
20/07/200507/06/2005A pilot study to investigate the use of recombinant cholera toxin B subunit in the treatment of active Crohn’s disease.A pilot study to investigate the use of recombinant cholera toxin B subunit in the treatment of active Crohn’s disease. Inflammatory Bowel Disease (IBD) is the comprehensive term for disorders involving chronic inflammation in the gastrointestinal tract, often the small intestine and colon. It is believed to be a disorder mediated by T lymphocytes that arise in genetically susceptible persons as a result of a breakdown in the regulatory constraints on mucosal immune responses to enteric bacteria. Evidence suggests that Th1 T cells play an important pathogenetic role in Crohn´s disease.
Level: PTClassification code 10011401
Product Name: rCTB-401
Other descriptive name: rCTB-401
SBL Vaccin ABNULLNot RecruitingFemale: yes
Male: yes
25Sweden